In 2009, Liu and coworkers reported that BMP2 expression became significantly higher as the glioma's grade advanced (P < 0.001) and the Karnofsky Performance Status (KPS) score decreased [39]. This evidence concerns the gene BMP2 and central nervous system cancer.